zalcitabine has been researched along with Hypertrophy, Left Ventricular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abuin, A; Cucoranu, I; Fields, E; Green, E; Hosseini, SH; Hoying, A; Ivey, K; Kohler, JJ; Lavie, A; Lewis, W; Raper, CM; Russ, R; Santoianni, R; Yang, Q; Zhelyabovska, O | 1 |
1 other study(ies) available for zalcitabine and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Transgenic cardiac-targeted overexpression of human thymidylate kinase.
Topics: Animals; Anti-HIV Agents; DNA Replication; DNA, Mitochondrial; Echocardiography; Emtricitabine; Female; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Transgenic; Mitochondria, Heart; Myocardium; Nucleoside-Phosphate Kinase; Nucleosides; Phosphorylation; Ventricular Function, Left; Zalcitabine; Zidovudine | 2010 |